Skip to content
  • 6,812 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Special notice

Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder

NOI-PCA-NIDA-09054

National Institutes of Health, National Institutes of Health. Testing Laboratories and Services.

23 open like this View on SAM.gov Markdown

Awarded

Novogene Corporation Inc.

$24,999.99 obligated so far on USAspending

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2026

23 like it are open now in testing laboratories and services

All 23 open in testing laboratories and services

Description

As published on SAM.gov.

Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work. 

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Novogene Corporation Inc.
UEI
KM6KF2YEWNN6
CAGE
7FRQ3
Vendor location
Sacramento, CA
Contract
75N98026P01685, purchase order
Obligated
$24,999.99
Actions
1 between September 21, 2026 and September 21, 2026
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Pharmacogenomic Analysis Services of Participants Enrolled in the Star-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Match
solicitation number NOIPCANIDA09054 equals the FPDS solicitation identifier; same sub-agency 7529 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 8, 2026

    Special notice

    Due September 15, 2026 at 3:00 PM EDT. SAM.gov, notice c0fa055913f647c4b3262722fd66122f

    1 revisions on SAM
    • September 8, 2026: publish, special notice

Points of contact